Compound Detail
CHEMBL4788145
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4788145 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QISLCMRYXKCYBN-UHFFFAOYSA-N |
7
Targets
7
Activities
1
Assay Types
0
PK Parameters
8
Publications
0
Known Names
Molecular Properties
478.4
MW (Da)
6.81
ALogP
4
HBA
0
HBD
32.6
PSA (Ų)
0.32
QED
1
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 5.09
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HepG2 CHEMBL395 | IC50 | 5.09 | 5.09 | 8200.0 | 1 |
| PC-3 CHEMBL390 | IC50 | 5.03 | 5.03 | 9300.0 | 1 |
| A549 CHEMBL392 | IC50 | 4.61 | 4.61 | 24400.0 | 1 |
| DLD-1 CHEMBL614285 | IC50 | 4.45 | 4.45 | 35900.0 | 1 |
| DU-145 CHEMBL613508 | IC50 | 4.44 | 4.44 | 36600.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.43 | 4.43 | 36700.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.15 | 4.15 | 70700.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 8200.0 | nM | 5.09 | Anticancer activity against human HepG2 cells assessed as cell growth inhibition... | 30772606 |
| PC-3 | IC50 | = | 9300.0 | nM | 5.03 | Anticancer activity against human PC-3 cells assessed as cell growth inhibition ... | 30772606 |
| A549 | IC50 | = | 24400.0 | nM | 4.61 | Anticancer activity against human A549 cells assessed as cell growth inhibition ... | 30772606 |
| DLD-1 | IC50 | = | 35900.0 | nM | 4.45 | Anticancer activity against human DLD-1 cells assessed as cell growth inhibition... | 30772606 |
| DU-145 | IC50 | = | 36600.0 | nM | 4.44 | Anticancer activity against human DU-145 cells assessed as cell growth inhibitio... | 30772606 |
| MDA-MB-231 | IC50 | = | 36700.0 | nM | 4.43 | Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhib... | 30772606 |
| MCF7 | IC50 | = | 70700.0 | nM | 4.15 | Anticancer activity against human MCF7 cells assessed as cell growth inhibition ... | 30772606 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30772606 | 10.1016/j.ejmech.2019.02.003 | MCF7 | 1 |
| 30772606 | 10.1016/j.ejmech.2019.02.003 | MDA-MB-231 | 1 |
| 30772606 | 10.1016/j.ejmech.2019.02.003 | DU-145 | 1 |
| 30772606 | 10.1016/j.ejmech.2019.02.003 | PC-3 | 1 |
| 30772606 | 10.1016/j.ejmech.2019.02.003 | HepG2 | 1 |
| 30772606 | 10.1016/j.ejmech.2019.02.003 | DLD-1 | 1 |
| 30772606 | 10.1016/j.ejmech.2019.02.003 | A549 | 1 |
| 30772606 | 10.1016/j.ejmech.2019.02.003 | HEK293 | 1 |
Data from ChEMBL 36 via Core Engine